Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers

Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers

Breast cancer (BC) is the most common form of cancer among women worldwide. Despite the huge advancements in its treatment, the exact etiology of breast cancer still remains unresolved. There is an increasing interest in the role of the gut microbiome in modulating the anti-cancer therapeutic respon...

Full description

Bibliographic Details
Main Authors: Oumaima Zidi, Nessrine Souai, Henda Raies, Farhat Ben Ayed, Amel Mezlini, Sonia Mezrioui, Fabrice Tranchida, Jean-Marc Sabatier, Amor Mosbah, Ameur Cherif, Laetitia Shintu, Soumaya Kouidhi
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Molecules
Subjects:
breast cancer (BC)
metabolomics
gut microbiota
dysbiosis
metabolites
biomarkers
Online Access:https://www.mdpi.com/1420-3049/26/8/2266

Internet

https://www.mdpi.com/1420-3049/26/8/2266

Similar Items